How nerves signal the body in health and overweight
Part of Hormones & metabolism clinical trials.
This study looks at how your brain sends signals to your body, comparing healthy people and those who are overweight. You'll help researchers understand differences in nerve communication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your BMI must be between 20 and 24.9 (healthy weight) or over 28 (overweight).
- If you are a woman of childbearing age, you must use a single-phase hormonal contraceptive (like Nuvaring).
- You cannot smoke or have a history of drug or alcohol abuse.
- You cannot take certain medications that affect blood sugar or the nervous system (like antidepressants, beta blockers, or seizure drugs).
- You cannot have heart, neurological, or certain other medical conditions (like glaucoma, thyroid problems, or liver/kidney issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This study looks at how people with different body weights digest and process sugar after a meal. Participants will eat a special breakfast and have blood and possibly stool tests to track a safe, low-dose radioactive label in the sugar. The goal is to understand why body weight affects sugar metabolism.
This early-phase study looks at how the body’s hormone signals and nerve control affect insulin release after gastric bypass surgery. It may help researchers understand what drives low blood sugar and how to better monitor or treat it.
This research study explores how obesity and insulin sensitivity (how well your body processes sugar) affect how your brain makes decisions and processes rewards. You'll undergo brain imaging and blood tests to help scientists understand these connections.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
Hear when a new Autonomic Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.